Ireland vs Trinidad and Tobago: HIV-positive TB patients on ART (antiretroviral therapy)
Ireland
38.0%
in 2024
Trinidad and Tobago
51.0%
in 2024
Ireland rank
142nd
Trinidad and Tobago rank
139th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Ireland
- Trinidad and Tobago
How they compare
Trinidad and Tobago currently reports 51.0% against 38.0% in Ireland, a difference of 13.0%.
That makes Trinidad and Tobago's figure about 1.3 times Ireland's.
The two have swapped places 2 times across 12 shared years of data; in 2012 it was Trinidad and Tobago ahead.
Ireland ranks 142nd and Trinidad and Tobago ranks 139th of 144 countries.
Across the 2 decades both report, Ireland averaged higher in 1 and Trinidad and Tobago in 1.
Head to head by decade
| Decade | Ireland | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 48.1% | 46.8% | 1.4% | Ireland |
| 2020s | 70.2% | 77.0% | 6.8% | Trinidad and Tobago |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Ireland or Trinidad and Tobago?
- Trinidad and Tobago, at 51.0% against 38.0% in Ireland as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Ireland and Trinidad and Tobago?
- 13.0%, with Trinidad and Tobago ahead.
- How many years of comparable data are there for Ireland and Trinidad and Tobago?
- 12 years are reported by both, from 2012 to 2024.
- How do Ireland and Trinidad and Tobago rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Ireland ranks 142nd and Trinidad and Tobago ranks 139th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.